Disease Info Card

Mitochondrial Myopathies

Information about Mitochondrial Myopathies: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Mitochondrial Myopathies

Most recent studies have shown that Mitochondrial Myopathies shares some biological mechanisms with acidosis, acidosis-lactic, atrophy, cardiomyopathies, chronic-progressive-external-ophthalmoplegia, cytochrome-c-oxidase-deficiency, diabetes-mellitus, encephalopathies, epilepsy, external-ophthalmoplegia, kearns-sayre-syndrome, melas-syndrome, merrf-syndrome, mitochondrial-diseases, mitochondrial-encephalomyopathies, muscle-weakness, myopathy, neuromuscular-diseases, ophthalmoplegia, weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Mitochondrial Myopathies, and have been seen in publications frequently: Aging, Cardiac Conduction, Cell Death, Electron Transport, Electron Transport Chain, Fatty Acid Beta-oxidation, Fatty Acid Oxidation, Glycolysis, Lipid Storage, Localization, Mitochondrial Translation, Muscle Atrophy, Muscle Contraction, Oxidative Phosphorylation, Pathogenesis, Pyruvate Oxidation, Regeneration, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Mitochondrial Myopathies, such as CHKA, CHKB, COX5A, COX8A, CPOX, CS, CSF2, CYCS, INS, LAMC2, MRRF, POLG, RYR1, SLC25A4, TK2, TYMP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.